The US pharmaceutical industry expressed support for the US Food and Drug Administration’s (FDA) proposed framework for ...
Manufacturing deals saw an unusual burst of recent activity, with a spike in the number of CDMOs acquiring facilities from pharma companies.
Pharma’s reputation among patient groups rose last year, but concerns remain over access and pricing
The pharma industry saw its reputation among patient groups inch up last year, a new survey finds, but concerns remain over ...
Top API Manufacturer Expands Innovation and Global Supply Capabilities in Pharmaceutical Development
Zhejiang Hengkang Pharmaceutical Co., Ltd. continues to strengthen its position as a leading manufacturer within the global active pharmaceutical ingredient industry, attracting growing attention for ...
The pharmaceutical sector, a beacon of innovation, stands tall in Europe's economic landscape. Yet even a robust industry is not immune to financial challenges. With a market value exceeding $280 ...
2UrbanGirls on MSN
Building AGI for pharmaceutical industry, Deep Intelligent Pharma secures another US$60 million in funding
AI pharmaceutical-development unicorn Deep Intelligent Pharma has recently completed a new financing round of US$60 mill ...
Pharmaceutical companies breathed a sigh of relief Wednesday after U.S. President Donald Trump revealed that they would not be subject to reciprocal tariffs — but that reprieve could prove fleeting.
Zacks Investment Research on MSN
Should you invest in the iShares US Pharmaceuticals ETF (IHE)?
The iShares U.S. Pharmaceuticals ETF (IHE) was launched on May 1, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the ...
Growth investors often keep a close eye on the pharmaceutical/biotech sector because of the high risk-high reward nature of investing in young companies developing novel drugs. When economic growth ...
Roche’s leadership shuffle, which began in July, continued on Monday with the departure of pharma sector CEO Bill Anderson. Anderson, formerly the boss of Roche subsidiary Genentech, took over as ...
6don MSNOpinion
Americans want big pharma reform. Candidates should deliver
Having spent 12 years on Capitol Hill, I know just how rare it is to find an issue with real bipartisan consensus. That’s why ...
This explains how the regulatory framework strictly governs drug quality, manufacturing, and liability. Courts have clarified that liability cannot be imposed without clearly identifying the role of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results